BioCentury | Dec 2, 2020
Distillery Therapeutics
Blocking PCSK9 alone or with anti-PD-1 therapies for cancer
...for licensing or partneringPUBLICATION DETAILS: Liu, X. et al. Nature; published online Nov. 11, 2020doi:10.1038/s41586-020-2911-7CONTACT: Chuan-Yuan Li, Duke University Medical Center...
...Repatha (Other) Praluent (Brand), SAR236553/REGN727 (Compound #), SAR236553 (Compound #), REGN727 (Compound #), alirocumab (Generic), Praluent (Other) Duke University Medical Center Proprotein...
...Repatha (Other) Praluent (Brand), SAR236553/REGN727 (Compound #), SAR236553 (Compound #), REGN727 (Compound #), alirocumab (Generic), Praluent (Other) Duke University Medical Center Proprotein...